Drug Regulatory Conferences for Canada
In Canada, as with all countries with regulatory agencies, there are specific regulatory pathways and processes for health products to be authorized for use in clinical trials or to obtain market approval. Here we highlight a handful of drug regulatory conferences for Canada that you can attend to learn more about Health Canada’s criteria and perhaps even meet organizations, regulatory experts or consulting firms that can help with your regulatory needs for Canada.
List of Drug & Medtech Regulatory Conferences for Canada
Event Summary
Canada’s Regulatory & Quality Medtech Conference 2025, presented by Medtech Canada, brings together regulatory and quality professionals from across the MedTech industry for informative sessions and valuable networking opportunities.
Attendees will hear from and be able to engage with Health Canada and other stakeholders in an open-dialogue environment. The conference is set to take place on April 23, 24 & 25, 2025 at the John G. Diefenbaker Building (11 Sussex Drive, Ottawa, Ontario). In-person and virtual participation options will be available.
What to expect from the conference
Your time is valuable! Medtech Canada’s Education & Training Committee is working hard to ensure the most relevant topics are brought forward during this conference and would like to thank all of those that participated in providing their feedback on the 2024 conference. Below are just some of the features of Canada’s Regulatory & Quality Medtech Conference:
- 3 day event, allowing for more content
- Networking opportunities including an afternoon reception
- Recorded sessions which can be viewed through the virtual event portal
Informaconnect- Pharma & Medtech Compliance Congress Canada
June 2 & 3, 2025
Toronto, Canada
Event Summary
Delivering Everything You Need For Pharmaceutical & MedTech Compliance Excellence.
PCC Canada returns this year to Toronto with advanced insights on the hottest topics and key challenges facing Canadian bio/pharmaceutical and medical technology professionals today. As the industry’s must-attend event covering the Canadian healthcare compliance landscape, this Congress keeps you on the pulse of the latest code considerations and explores innovative strategies to optimize compliance operations and risk management. With session topics focused on showcasing key regulatory considerations and top emerging risk areas such as AI and privacy and two featured customizable track options, this conference covers it all. Join experts across the life sciences community in this exclusive opportunity to unite with industry peers to benchmark, collaborate and explore how to stay ahead of evolving code changes and future-proof your compliance program against top emerging risk areas.
Event Summary
Goal: The Society of Clinical Research Associates (SOCRA) recognizes the continuing need for education for Clinical Research Professionals responsible for the activities at the research site or institution. The purpose of this workshop is to assist Research Professionals in improving their skills and their understanding of the responsibilities of conducting clinical research in Canada.
Objective: The goal will be accomplished through lecture and practical application facilitated by clinical research professionals. Information will be presented and discussed regarding the administration of clinical trials according to Health Canada Regulations and International Council for Harmonisation (ICH) guidelines as well as practical procedures and site / sponsor / CRO relationships.
Learning Objectives: Upon completion of the conference, the attendee should be able to:
- Discuss opportunities and challenges facing the clinical research industry.
- Discuss the challenges, opportunities, and best practices with Decentralized Clinical Trials.
- Discuss the responsibilities of an investigator as outlined in ICH E6(R2) Guidelines Sections 4.1to 4.13.
- Discuss regulation of investigational testing of medical devices in human in Canada, including limitations and key considerations.
- Discuss the regulatory framework governing CTA and review process at Health Canada.
- Discuss FDA’s role in the oversight of clinical trials that are conducted in Canada.
- Discuss tools and resources researchers can access to learn more about best practices in RDM.
- Discuss the sources of data and data itself that Data Management collects outside of the CRFs or EDC System.
- Discuss how REDCap has been used Health Canada regulated clinical trials.
- Discuss challenges and potential solutions for improving diverse clinical trials participation.
- Discuss how to build a better site/sponsor relationship, with an emphasis on the monitor role.
- Discuss how to best be prepared for a GCP inspection or audit.
BIO International Convention - Canada Pavillion
June 16 to 19, 2025
Boston, United States
Event Summary
The BIO International Convention is the largest and most comprehensive event for biotechnology, representing the full ecosystem of biotech with 20,000 industry leaders from across the globe.
Once again, BIOTECanada led the Canadian delegation and managed the installation of the Canadian Pavilion with partners from across Canada. BIOTECanada is the national industry association voice for the Biotech industry in Canada. BIOTECanada along with the provincial Accord members, the Government of Canada and the Quebec provincial government offered fantastic Canadian programming, and the agenda of activities built on the policy initiatives Canada has established to showcase the innovation and research capacity driving new economic success.
Over 4 days, the Canada Pavilion showcased our life sciences ecosystem and the many opportunities for collaboration within the sector, program panelists and dignitaries provided invaluable perspectives on the rapidly evolving industry.
Event Summary
The Canadian Association of Professionals in Regulatory Affairs (CAPRA) is a non-profit organization that serves the pharmaceutical, biologics, medical device, cosmetic and natural health product industries in Canada.
CAPRA hosts a one-day pharmaceutical symposium with Health Canada and Industry leaders. This unparalleled collaborative event will provide a unique opportunity to hear about the Canadian Pharmaceutical industry directly from those involved in the Regulatory sector..
Event Summary
The DIA Canada Annual Meeting will provide an in-depth exploration of the current pharmaceutical, medical device, and diagnostic landscapes in Canada, emphasizing Canada’s pivotal role in global healthcare product development. Offering three specialized tracks on Regulatory, Clinical, and Safety and Pharmacovigilance, the meeting will cover topics spanning from Health Canada’s latest regulatory initiatives, international collaboration, and innovative clinical practices to approaches that harness AI in drug safety and increase representation from equity-denied groups.
Attendees will have the opportunity to engage with leaders and experts from academia, regulatory bodies, and the pharmaceutical and medical device industries by gaining insights into best practices, lessons learned, and strategies to address the challenges facing stakeholders in Canada.
FURTHER INFORMATION
- Review our popular guide on the “Overcoming Obstacles in Drug Approval Process in Canada“
- Review our post on “How to Pick the Right Regulatory Affairs Professional“
For further information about the drug review & approval process in Canada, or about the New Drug Submission Process with Health Canada or to have a complementary discussion about your needs, please contact SPharm directly.
Featured Posts
With a quarter of a century of consistent and successful results, SPharm has become one of the leading Drug Regulatory Advisory firms in Canada. Drug companies from around the world count on SPharm to help them navigate the drug (and other health products) review & approval process in Canada.
Avec un quart de siècle de résultats et de succès constants , SPharm est devenue une entreprise de services de référence au Canada en stratégie de développement de médicaments et affaires réglementaires. Des compagnies pharmaceutiques à travers le monde comptent sur SPharm pour faciliter le processus d’homologation de leurs médicaments (et autres produits de santé) au Canada.